chronic kidney disease

Pharma

GSK's anemia drug Jesduvroq scores FDA green light

The FDA approved the drug for patients who are on dialysis. Safety in the non-dialysis patient population "has not been established," the agency said.
Zoey Becker Feb 2, 2023 8:30am

AZ targets people who don't know they have CKD in new spot

Jan 27, 2023 7:30am

Unicycive's pivotal trial of Takeda kidney drug rival hits goal

Jan 3, 2023 7:30am

Travere teams up with patient groups for new kidney campaign

Nov 21, 2022 7:55am

After pair of losses, Ardelyx's CKD prospect finds FDA foothold

Nov 17, 2022 8:05am

FDA flags concerns about Ardelyx's kidney disease prospect

Nov 15, 2022 10:48am